Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma

Clinical trial NCT04652492 · UNKNOWN

Trial details

NCT number: NCT04652492
Sponsor: Zhongda Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2020-10-27
Primary completion: 2022-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.